NEI
CGON icon

Northwest & Ethical Investments’s CG Oncology CGON Stock Holding History

Northwest & Ethical Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.4K Sell
1,185
-1,955
-62% -$128K ﹤0.01% 485
2026
Q1 		$212K Buy
+3,140
New +$178K ﹤0.01% 483

Other funds holding CGON

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northwest & Ethical Investments's CGON Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its CG Oncology (CGON) stake by 62% in Q2 2026, selling an estimated $128K and leaving 1,185 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Northwest & Ethical Investments first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. The position peaked at $212K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Northwest & Ethical Investments held 1,185 shares of CG Oncology worth $87.4K as of Q2 2026.
  • Northwest & Ethical Investments sold 1,955 CG Oncology shares in Q2 2026, an estimated $128K.
  • CG Oncology made up ﹤0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #485 holding.
  • Northwest & Ethical Investments first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • Northwest & Ethical Investments's CG Oncology position peaked at $212K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.